Founded in June 1923 as a Swedish manufacturing enterprise that specialized in repairing forestry equipment, the company management soon realized the enormous potential of leveraging their precision engineering skills in an emerging medical technology market.

The company embarked on a journey partnering with healthcare professionals, research institutions and industry experts worldwide. A collaboration with Professor Per-Ingvar Brånemark paved the way for revolutionizing modern dental implants. Elos Medtech manufactured the world's first durable insulin pen that was brought to market, and for nearly 20 years Elos Medtech has been supporting the current transformation of the orthopedic market with decades long involvement with surgical navigation and robotic assisted surgery.

Elos Medtech has consistently remained at the forefront of the medical device industry innovation. In 2008, Elos Medtech, at that time AB Westergyllen, listed on the Nasdaq OMX Nordic under the HealthCare Category signaling complete commitment to the healthcare sector.

Today Elos Medtech is a valued industry leader known for quality, precision, and customer satisfaction all underpinned by the core values of being passionate about changing lives, trusted to deliver as promised, results focused and working collaboratively with internal and external teams.

Elos Medtech attributes its success and longevity to that unwavering focus on building partnerships based on innovation, product excellence and customer focus. With a global presence spanning three continents and four countries (Sweden, Denmark, China, and the USA), the company, has established itself as a trusted partner for medical device companies worldwide, with the average key customer relationship lasting 30 years.

Commenting on the milestone Stefano Alfonsi, CEO of Elos Medtech said: "Reaching 100 years is a significant milestone in our industry. I express my sincere appreciation to all our employees for their resolute commitment to our culture of collaboration and product excellence. They show the ability to conceive and implement innovation, which combined with state-of-the-art manufacturing facilities, advanced technology, and stringent quality standards, ensures the delivery of high-quality products that satisfy even the most demanding customer requirements. As we enter our second century, we remain committed to working sustainably and expanding our global presence through organic growth, synergistic acquisitions and investments, bringing product excellence and flexible thinking to more customers worldwide."

To commemorate our 100 year anniversary, Elos Medtech has planned a series of events and celebrations with customers and employees around the globe designed to give back to our people and our communities.

For more information about Elos Medtech and its centennial celebrations, please visit www.elosmedtech.com  or visit our Linkedin page www.linkedin.com/company/elosmedtech/

About Elos Medtech

Elos Medtech is a leading development and production partner for medical devices and components, with a focus on dental and orthopedic implants and instruments. The company operates from facilities in Sweden, Denmark, China, and the U.S. The customer base comprises international medical technology companies.

Elos Medtech has more than 650 employees and a turnover of approximately SEK 950 million. Elos Medtech has been listed on NASDAQ Stockholm AB since 1989. Elos Medtech's B share is categorized as a Health Care company on the Mid Cap list.

Gothenburg, June 26, 2023

Elos Medtech AB (publ)

For more information, please contact:

Stefano Alfonsi, President and CEO, +44 772 04 98 342, stefano.alfonsi@elosmedtech.com.
Jodie Gilmore, Chief Commercial & Operations Officer, +1 901 323 6699, jodie.gilmore@elosmedtech.com